SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280 | +118.8% | 2,325 | +104.8% | 0.00% | – |
| Q2 2023 | $128 | +37.6% | 1,135 | +66.9% | 0.00% | – |
| Q1 2023 | $93 | +17.7% | 680 | +9.1% | 0.00% | – |
| Q4 2022 | $79 | -100.0% | 623 | -63.6% | 0.00% | – |
| Q3 2022 | $188,000 | +138.0% | 1,713 | +61.0% | 0.00% | – |
| Q2 2022 | $79,000 | 0.0% | 1,064 | +4.0% | 0.00% | – |
| Q1 2022 | $79,000 | -38.8% | 1,023 | -29.1% | 0.00% | – |
| Q4 2021 | $129,000 | -20.4% | 1,443 | -17.9% | 0.00% | – |
| Q3 2021 | $162,000 | +8.0% | 1,758 | -9.5% | 0.00% | – |
| Q2 2021 | $150,000 | -69.1% | 1,943 | -70.2% | 0.00% | -100.0% |
| Q1 2021 | $485,000 | -90.4% | 6,511 | -78.1% | 0.00% | -83.3% |
| Q4 2020 | $5,064,000 | +9107.3% | 29,705 | +7382.4% | 0.01% | – |
| Q3 2020 | $55,000 | -37.5% | 397 | -28.1% | 0.00% | – |
| Q2 2020 | $88,000 | -18.5% | 552 | -50.4% | 0.00% | – |
| Q1 2020 | $108,000 | +3500.0% | 1,112 | +4533.3% | 0.00% | – |
| Q4 2019 | $3,000 | -76.9% | 24 | -86.2% | 0.00% | – |
| Q3 2019 | $13,000 | -88.1% | 174 | -82.6% | 0.00% | – |
| Q4 2018 | $109,000 | -32.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $161,000 | -83.5% | 1,000 | -86.4% | 0.00% | -100.0% |
| Q2 2018 | $973,000 | – | 7,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |